Already a member? Login to access this report free.
Report Highlights
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Report Includes
- 57 data tables and 152 additional tables
- Evaluation of the current and future market potential of the pharmaceutical industry, featuring a look at the competitive landscape of the 50 leading pharmaceutical manufacturers
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021-2024, and projected CAGRs through 2029
- Discussion of the opportunities in the pharmaceutical industry, along with an evaluation of the competitive environment, regulatory landscape, and technological trends and advances
- A look at the regulatory and pricing scenarios in the global market, with an emphasis on recently enacted regulations in the U.S., Europe and Japan
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Analysis of patent activity, including key granted and published patents
- Descriptive company profiles of the leading pharma manufacturers, including Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Merck & Co. Inc., and F. Hoffmann La Roche Ltd.
Report Scope
This research report analyzes the global market for pharmaceutical drugs and its competitive landscape through 2029. It covers leading manufacturers of pharmaceutical drugs and the companies providing pharmaceutical services to biopharma and pharmaceutical firms), competitive intelligence and technological advances. The analysis includes recent developments in the product portfolios of major companies, as well as market share and rankings. The regulatory landscape analysis focuses on recent regulations in the U.S., Europe, and Japan. BCC Research estimated market size data for 2023 (base year) and forecast values for 2024 through the end of 2029. This report also examines drivers, restraints, and opportunities in the global market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Base year market size | $1.6 Trillion | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Market size forecast | $2.2 Trillion | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Growth rate | CAGR of 5.5% for the forecast period of 2024-2029 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Units considered | $ Billions | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, Middle East and Africa | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
This report discusses exhaustive coverage of the pharmaceutical industry and its competitive landscape in terms of major player market ranking and top pharmaceutical drugs. Company profiles of the top fifty pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well researched and analyzed in this report. The study include tracking alliances, joint ventures, mergers and acquisitions, new product development and R&D in the global pharmaceutical drugs market and the factors that will affect the industry in the coming years.
Report Includes
- 71 data tables and 54 additional tables
- A brief general overview of the global pharmaceutical drugs industry competitive landscape
- Analyses of the global market trends, with historic market revenue for 2016 to 2021, estimates for 2022, market forecasts for 2022-2026, and projections of compound annual growth rates (CAGRs) through 2027
- Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on recent developments in the pharmaceutical industry
- Highlights of the current and future market potential of pharmaceutical industry along with a detailed analysis of the competitive environment, regulatory scenario and clinical trails
- Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on recent developments and region-specific macroeconomic factors on global pharmaceutical drugs marketplace
- Market assessment of the COVID-19 impact on the global pharmaceutical drugs market, along with its implications on demand and supply, price impact and various government strategic decisions
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading pharma manufacturers, including Abbott, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Pfizer Inc., Sanofi Corp., Takeda Pharmaceutical Co. Ltd. and Zydus Cadila
Related Reports
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Multi-Cancer Diagnostic Tests: Global Market Outlook
This report provides an in-depth analysis of the global multi-cancer diagnostic (MCD) test market. It highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Next-Generation Cancer Diagnostics: Technologies and Global Markets
The global next-generation cancer diagnostics market reached $8.7 billion in 2022 and should reach $15 billion by 2027, with a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2022-2027.
Recent Reports
Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets
The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
The Global Influenza Market
The global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029.
Liver Disease Treatments: The Global Market
The global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.
Cancer Immunotherapy: Technologies and Global Markets
The global cancer immunotherapy market is expected to grow from $144.2 billion in 2024 and is projected to reach $247.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2024 to 2029.
Top Trending Reports
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Global Diabetic Care Devices Market
The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.
Single-Cell Genomics and Proteomics: Emerging Technologies and Markets
The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.
Global Lithium-ion Battery Market
The global market for lithium-ion battery (LIB) is expected to grow from $117.8 billion in 2024 and is projected to reach $221.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More